Skip to main content
. 2018 Oct 15;3(3):146–159. doi: 10.1002/jin2.51

Figure 7.

Figure 7

Intraductal treatment with DOX and PEG‐DOX nanocarriers increased survival in the orthotopic breast cancer model. (A) Rats treated with intraductal therapy (ID); (B) rats treated with intravenous therapy (IV). There is insignificant difference among all ID‐treated groups (A). DOX, doxorubicin; PEG, poly(ethylene glycol).